EXFORGE

This brand name is authorized in Austria, Australia, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug EXFORGE contains a combination of these active pharmaceutical ingredients (APIs):

1 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

2 Valsartan UNII 80M03YXJ7I - VALSARTAN

Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II. Read about Valsartan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EXFORGE Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DB01	Valsartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5459H, 5460J, 9375K, 9376L, 9377M
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00012931, 00013534, 00014350, 00581327, 00581356, 00581391, 00581422, 00581474, 00581497, 01231799, 04708813, 05386688, 05386694, 06142617, 06142652, 06142681, 06439406, 06439412, 06441343, 06441366, 07052419, 07289593, 07289624, 07289653, 09194425, 09543506, 09543512, 09779019, 09779456, 09779462, 10066253, 10114785, 10114791, 10114816, 10114822, 10114839, 10114845, 10114851, 10114868, 10172736, 10288574, 10298354, 10298383, 10789313, 11045951, 11089730, 11380069, 11515782, 12483185, 12483191, 12483216, 12483222, 12561229, 15235281, 16008825, 16528418, 17523133, 17847433
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2208-MEE-0616, 2459-MEE-0916, 29728-04-11, 29739-04-11, 29987-09-11
Country: EE	Ravimiamet	Identifier(s): 1235528, 1235539, 1235540, 1235551, 1235562, 1235573, 1235584, 1235595, 1235607, 1235618, 1235629, 1235630, 1235641, 1235652, 1235663, 1235674, 1235685, 1235696, 1235708, 1235719, 1235720, 1235731, 1235742, 1235753
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06370011, 06370019
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 074042, 074051, 074060, 074069, 074078, 074087
Country: FR	Base de données publique des médicaments	Identifier(s): 60058008, 61695837, 66996659
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 111612, 111616, 111619, 196118, 196120, 196122, 374370, 374372
Country: HK	Department of Health Drug Office	Identifier(s): 56183, 56184, 56185, 59786, 59787, 60451, 60452, 60453
Country: IE	Health Products Regulatory Authority	Identifier(s): 23401, 23410, 23419, 23423, 23425, 32627, 32628, 32651, 32660, 32661, 32663
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6145, 6146, 6148
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149114F1021, 2149114F2028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005477, 1005478, 1028134, 1028135, 1028136, 1028137, 1028138, 1028139, 1028140, 1028141, 1028142, 1028143, 1028145, 1028146, 1028147, 1028148, 1028149, 1028150, 1028151, 1028153, 1028154, 1028155, 1028156, 1028157, 1056612, 1056613, 1056614, 1056615, 1056616, 1056617, 1056618, 1056619, 1056620, 1056621, 1056622, 1056623, 1058745, 1058746, 1058747
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 159M2007
Country: NG	Registered Drug Product Database	Identifier(s): B4-1701
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 82686, 82694, 82708
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12433, 12434, 12435
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100171336, 100174174, 100174180
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64721001, W64721002, W64721003, W64721004, W64721005, W64721006, W64721007, W64721008, W64721009, W64721010, W64721011, W64722001, W64722002, W64722003, W64722004, W64722005, W64722006, W64722007, W64722008, W64722009, W64722010, W64722011, W64723001, W64723002, W64723003, W64723004, W64723005, W64723006, W64723007, W64723008, W64723009, W64723010, W64723011
Country: SG	Health Sciences Authority	Identifier(s): 13416P, 13417P, 13418P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283201, 10283202, 10283203
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504091199, 8699504091205
Country: US	FDA, National Drug Code	Identifier(s): 0078-0488, 0078-0489, 0078-0490, 0078-0491
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/7.1.3/0290, 41/7.1.3/0291, 41/7.1.3/0292, 41/7.1.3/0770, 41/7.1.3/0771